BMI View: Zimbabwe's ongoing economic crisis is continuing to take a toll on the country'spharmaceutical and healthcare sector. Severely underfunded public healthcare services and high povertylevels have made access to formal treatments difficult, with many turning to traditional healers instead.Despite government pledges to improve healthcare access in recent years, we have yet to see anysubstantial developments, with the country still heavily reliant on international aid for essential medicines.Further issues including a high abundance of counterfeit drugs and political instability make Zimbabwe oneof the least attractive markets in the region for multinational drugmakers.Headline Expenditure ProjectionsPharmaceuticals: USD380mn in 2015 to USD400mn in 2016; +4.7% in US dollar terms. Forecastunchanged from last quarter.
Table Of Contents
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2016 BMI Industry View 7 Table: Headline Pharmaceuticals and Healthcare Forecasts (Zimbabwe 2014-2020) 7 SWOT 9 Industry Forecast 11 Pharmaceutical Market Forecast 11 Table: Pharmaceutical Sales, Historical Data And Forecasts (Zimbabwe 2012-2020) 13 Healthcare Market Forecast 14 Prescription Drug Market Forecast 16 Patented Drug Market Forecast 17 Generic Drug Market Forecast 18 Pharmaceutical Trade Forecast 19 Table: Pharmaceutical Trade Data And Forecasts (Zimbabwe 2014-2020) 21 Industry Risk/Reward Index 22 Middle East and Africa Risk/Reward Index - Q3 2016 22 Zimbabwe Risk/Reward Index 30 Rewards 30 Risks 30 Regulatory Review 32 Regulatory Regime 32 Intellectual Property Issues 34 Pricing And Reimbursement Regime 35 Market Overview 38 Healthcare Sector 39 Table: Zimbabwe: Healthcare Facilities 39 Research and Development 45 Clinical Trials 46 Epidemiology 46 Competitive Landscape 49 Research-Based Industry 49 Table: Multinational Market Activity 50 Generic Drugmakers 51 Pharmaceutical Distribution and Retail Sector 52 Company Profile 53 Datlabs 53 Varichem Laboratories 55 Demographic Forecast 58 Table: Population Headline Indicators (Zimbabwe 1990-2025) 59 Table: Key Population Ratios (Zimbabwe 1990-2025) 59 Table: Urban/Rural Population and Life Expectancy (Zimbabwe 1990-2025) 60 Table: Population By Age Group (Zimbabwe 1990-2025) 60 Table: Population By Age Group % (Zimbabwe 1990-2025) 61 Glossary 63 Methodology 65 Pharmaceutical Expenditure Forecast Model 65 Healthcare Expenditure Forecast Model 65 Notes On Methodology 66 Risk/Reward Index Methodology 67 Index Overview 68 Table: Pharmaceutical Risk/Reward Index Indicators 68 Indicator Weightings 69